Asthma Spacers Market 2023-2030: Size, Share, and Growth Forecast The worldwide market for asthma spacers witnessed robust growth in 2021, with an estimated value of USD 1,982.4 million. Analysts predict the market will continue to expand at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period. Several factors contribute to this growth, including the increasing prevalence of chronic respiratory disorders, heightened awareness of spacer benefits, and augmented R&D investments by public and commercial entities. Access Full Report: https://www.fairfieldmarketresearch.com/report/asthma-spacers-
market
Chronic respiratory problems rank among the most common non-communicable diseases globally, with the World Health Organization (WHO) reporting 4,55,000 asthma-related deaths and 262 million affected individuals in 2019. Consequently, the usage of asthma spacer devices is anticipated to grow, propelling the market's expansion. The strategic moves and product innovations by key market players have also played a significant role in driving market growth. For example, Philip Morris International's acquisition of Vectura for USD 1.2 billion in 2021 highlights their commitment to inhaled treatments product pipeline development, leading to further market growth. COVID-19 has further impacted the asthma spacers market. The pandemic has increased the need for these devices as patients with respiratory symptoms sought treatment, including those affected by acute respiratory illness syndrome (ARDS). Moreover, the virus's transmissibility and risk of severe disease for asthma patients have driven the demand for asthma spacers. Many countries have recommended replacing small-volume nebulizers with asthma spacers, creating a favorable market opportunity. The rising prevalence of respiratory diseases, attributed to factors like air pollution and lifestyle changes, is a significant driver of the asthma spacers market. Air pollution is linked